…ousands of patients and investigators worldwide who participated in the ODYSSEY clinical trial program," said Leonard S. Schleifer, M.D., Ph.D., Founder, President, and Chief Executive Officer, Regeneron. "Praluent represents the culminatio...
Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today
TEXT-001-HOUSE_OVERSIGHT_025888.txt
p.1
View source release ↗